AEGERION PHARMACEUTICALS INC's ticker is AEGR and the CUSIP is 00767E102. A total of 156 filers reported holding AEGERION PHARMACEUTICALS INC in Q3 2013. The put-call ratio across all filers is 0.65 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2016 | $73,000 | -67.3% | 19,800 | -10.3% | 0.00% | – |
| Q4 2015 | $223,000 | -35.9% | 22,077 | -13.7% | 0.00% | – |
| Q3 2015 | $348,000 | +16.4% | 25,577 | +62.1% | 0.00% | – |
| Q2 2015 | $299,000 | -97.0% | 15,777 | -95.8% | 0.00% | -100.0% |
| Q1 2015 | $9,876,000 | +25.1% | 377,377 | +0.1% | 0.01% | +25.0% |
| Q4 2014 | $7,892,000 | -47.4% | 376,877 | -16.2% | 0.01% | -46.7% |
| Q3 2014 | $15,007,000 | +8.9% | 449,577 | +4.7% | 0.02% | +7.1% |
| Q2 2014 | $13,778,000 | -20.9% | 429,363 | +13.7% | 0.01% | -26.3% |
| Q1 2014 | $17,414,000 | +91.5% | 377,577 | +194.6% | 0.02% | +90.0% |
| Q4 2013 | $9,095,000 | -20.5% | 128,177 | -4.0% | 0.01% | -28.6% |
| Q3 2013 | $11,441,000 | -30.8% | 133,477 | -48.9% | 0.01% | -33.3% |
| Q2 2013 | $16,542,000 | – | 261,153 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| ADVENT INTERNATIONAL, L.P. | 447,001 | $14,344,000 | 100.00% |
| Broadfin Capital, LLC | 1,620,088 | $51,988,000 | 2.56% |
| SCOPIA CAPITAL MANAGEMENT LP | 2,899,585 | $93,048,000 | 2.40% |
| Tamarack Capital Management, LLC | 400,000 | $11,656,000 | 2.38% |
| March Altus Capital Management LP | 199,037 | $6,387,000 | 2.34% |
| PRICE MICHAEL F | 240,000 | $7,702,000 | 0.94% |
| DELTEC ASSET MANAGEMENT LLC | 106,151 | $3,406,000 | 0.72% |
| WESTFIELD CAPITAL MANAGEMENT CO LP | 3,207,598 | $102,932,000 | 0.61% |
| CLOUGH CAPITAL PARTNERS L P | 508,800 | $16,327,000 | 0.52% |
| Catalyst Capital Advisors LLC | 86,500 | $2,776,000 | 0.45% |